NYSE:INSP Inspire Medical Systems (INSP) Stock Price, News & Analysis $76.30 -0.07 (-0.09%) As of 10:17 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Inspire Medical Systems Stock (NYSE:INSP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get INSP alerts:Sign Up Key Stats Today's Range$75.96▼$77.4150-Day Range$72.42▼$131.4652-Week Range$70.77▼$216.01Volume74,734 shsAverage Volume732,876 shsMarket Capitalization$2.26 billionP/E Ratio44.20Dividend YieldN/APrice Target$154.43Consensus RatingHold Company Overview Inspire Medical Systems, Inc. is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices. The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve. The device received FDA approval in 2014 and has since obtained CE mark authorization for marketing in Europe. Inspire collaborates with a network of accredited sleep centers and specialized physicians to identify eligible patients and provide training, support and follow-up care. Founded in 2007 and headquartered in Golden Valley, Minnesota, Inspire Medical Systems serves markets across North America and Europe, with ongoing efforts to expand its commercial footprint in select international regions. The company is led by President and Chief Executive Officer Michael A. Moulder, supported by a management team with deep expertise in medical devices, regulatory affairs and commercial operations. Inspire remains focused on advancing its technology platform through clinical research, product enhancements and expanded physician education programs.AI Generated. May Contain Errors. Read More Inspire Medical Systems Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks97th Percentile Overall ScoreINSP MarketRank™: Inspire Medical Systems scored higher than 97% of companies evaluated by MarketBeat, and ranked 45th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.2 / 5Analyst RatingHold Consensus RatingInspire Medical Systems has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 7 buy ratings, 7 hold ratings, and 1 sell rating.Upside PotentialInspire Medical Systems has a consensus price target of $154.43, representing about 102.2% upside from its current price of $76.36.Amount of Analyst CoverageInspire Medical Systems has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Inspire Medical Systems' stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth49.07% Earnings GrowthEarnings for Inspire Medical Systems are expected to grow by 49.07% in the coming year, from $2.16 to $3.22 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inspire Medical Systems is 44.14, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 234.34.Price to Earnings Ratio vs. SectorThe P/E ratio of Inspire Medical Systems is 44.14, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 85.98.Price to Earnings Growth RatioInspire Medical Systems has a PEG Ratio of 2.39. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioInspire Medical Systems has a P/B Ratio of 3.32. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Inspire Medical Systems' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.80% of the float of Inspire Medical Systems has been sold short.Short Interest Ratio / Days to CoverInspire Medical Systems has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Inspire Medical Systems has recently increased by 11.49%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInspire Medical Systems does not currently pay a dividend.Dividend GrowthInspire Medical Systems does not have a long track record of dividend growth. Sustainability and ESG4.8 / 5Environmental Score-0.66 Percentage of Shares Shorted9.80% of the float of Inspire Medical Systems has been sold short.Short Interest Ratio / Days to CoverInspire Medical Systems has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Inspire Medical Systems has recently increased by 11.49%, indicating that investor sentiment is decreasing significantly. News and Social Media2.0 / 5News Sentiment0.61 News SentimentInspire Medical Systems has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Inspire Medical Systems this week, compared to 10 articles on an average week.Search Interest10 people have searched for INSP on MarketBeat in the last 30 days. This is an increase of 11% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Inspire Medical Systems to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Inspire Medical Systems insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,027,290.00 in company stock.Percentage Held by InsidersOnly 4.10% of the stock of Inspire Medical Systems is held by insiders.Percentage Held by Institutions94.91% of the stock of Inspire Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Inspire Medical Systems' insider trading history. Receive INSP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INSP Stock News HeadlinesInspire Medical Systems, Inc. to Report Third Quarter 2025 Financial Results on November 3, 2025October 6 at 8:00 AM | globenewswire.comINSPIRE MEDICAL (INSP) ALERT: Bragar Eagel & Squire, P.C. Reminds Investors of the Investigation into Inspire Medical Systems, Inc. and Encourages Investors to Contact the FirmOctober 3, 2025 | globenewswire.comGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real opportunity isn’t in coins or bullion. In every major gold rally of the past 50 years, there’s been another investment that has delivered dramatically higher returns.October 7 at 2:00 AM | Weiss Ratings (Ad)UBS Downgrades Inspire Medical Systems (INSP)September 23, 2025 | msn.comExpert Outlook: Inspire Medical Systems Through The Eyes Of 15 AnalystsSeptember 22, 2025 | benzinga.comInspire Medical Systems, Inc.'s (NYSE:INSP) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?September 22, 2025 | finance.yahoo.comThe Summers Value Fund Added Inspire Medical (INSP) to its Portfolio in Q2September 22, 2025 | insidermonkey.comInspire Medical Systems, Inc. (INSP) Navigates Market Pressure from GLP-1 Drugs, Plans 2026 GrowthSeptember 18, 2025 | finance.yahoo.comSee More Headlines INSP Stock Analysis - Frequently Asked Questions How have INSP shares performed this year? Inspire Medical Systems' stock was trading at $185.38 at the beginning of the year. Since then, INSP stock has decreased by 58.8% and is now trading at $76.36. How were Inspire Medical Systems' earnings last quarter? Inspire Medical Systems, Inc. (NYSE:INSP) released its quarterly earnings data on Monday, August, 4th. The company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.22 by $0.23. The firm's quarterly revenue was up 10.8% on a year-over-year basis. Read the conference call transcript. How will Inspire Medical Systems' stock buyback program work? Inspire Medical Systems' board initiated a stock buyback plan on Monday, August 11th 2025, which permits the company to buy back $200,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 8.6% of its shares through open market purchases. Shares repurchase plans are often a sign that the company's management believes its shares are undervalued. When did Inspire Medical Systems IPO? Inspire Medical Systems (INSP) raised $75 million in an initial public offering on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers. How do I buy shares of Inspire Medical Systems? Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Inspire Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some other companies that Inspire Medical Systems investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), UnitedHealth Group (UNH), Tesla (TSLA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ). Company Calendar Last Earnings8/04/2025Today10/07/2025Next Earnings (Estimated)11/03/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MEDICAL INFO SYS Sub-IndustryMedical Equipment Current SymbolNYSE:INSP CIK1609550 Webwww.inspiresleep.com Phone(844) 672-4357FaxN/AEmployees1,246Year Founded2007Price Target and Rating Average Price Target for Inspire Medical Systems$154.43 High Price Target$255.00 Low Price Target$89.00 Potential Upside/Downside+102.2%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage15 Analysts Profitability EPS (Trailing Twelve Months)$1.73 Trailing P/E Ratio44.14 Forward P/E Ratio35.35 P/E Growth2.39Net Income$53.51 million Net Margins6.17% Pretax Margin6.83% Return on Equity10.38% Return on Assets8.93% Debt Debt-to-Equity RatioN/A Current Ratio6.14 Quick Ratio4.84 Sales & Book Value Annual Sales$802.80 million Price / Sales2.81 Cash Flow$1.70 per share Price / Cash Flow44.82 Book Value$23.01 per share Price / Book3.32Miscellaneous Outstanding Shares29,570,000Free Float28,894,000Market Cap$2.26 billion OptionableOptionable Beta1.16 Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NYSE:INSP) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inspire Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inspire Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.